Concepedia

Eva Jerning

EJ

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

1986

Affiliations

AstraZeneca (Sweden)(Current)

Södertälje Sjukhus

Eva Jerning is an author at AstraZeneca (Sweden) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1986–2013

11

Publications

11

Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418

Ratan V. Bhat, Yafeng Xue, Stefan von Berg et al. · Journal of Biological Chemistry · 2003 · 538 citations · Full text

Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines

Stefan von Berg, Margareta Bergh, Sven Hellberg et al. · Journal of Medicinal Chemistry · 2012 · 145 citations · Full text

The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299

L. E. B. Johansson, Daniel Sohn, Seth-Olof Thorberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 130 citations · Full text

Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors

Håkan Hall, Maria Sällemark, Eva Jerning · Acta Pharmacologica et Toxicologica · 1986 · 101 citations · Full text

Substituted 7-Amino-5-thio-thiazolo[4,5-<i>d</i>]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX<sub>3</sub>CR1)

Sofia Karlström, Gunnar Nordvall, Daniel Sohn et al. · Journal of Medicinal Chemistry · 2013 · 68 citations · Full text

, , +18

1–5 of 11